|
Source
|
Web search |
|
Organization
|
University of Pennsylvania’s Perelman School of Medicine |
|
Website URL
|
www.pennmedicine.org/news/news-releases/2020/octobe… |
|
Market status
|
Early Stage Concept |
|
Industry
|
Medical |
|
Value chain stage
|
Input |
|
Business models
|
B2B + B2C |
|
Product categories
|
Medical Treatment |
|
Biotech components
|
Animal + Bacteria + Molecule |
|
Organization type(s)
|
University |
|
Funding types
|
University |
|
Notes
|
“The sting from a Korean yellow-jacket wasp doesn’t pose much of a danger to people—but it could be toxic enough to kill lethal bacteria that have become resistant to antibiotics. Now the insect has inspired scientists at the University of Pennsylvania’s Perelman School of Medicine to take a new approach to developing antibiotics...The team started with one ingredient in the wasp’s venom, a peptide called mastoparan-L (mast-L). This protein can kill bacteria, but it wouldn’t be safe for people at high doses. So the researchers engineered a version of the protein so that it targets E. coli while leaving healthy cells alone. They described the compound in the journal Proceedings of the National Academy of Sciences." |
Added 3 years ago
Last modified 3 years ago
